Search for: "Eli Lilly "
Results 921 - 940
of 2,131
Sorted by Relevance
|
Sort by Date
27 Feb 2007, 2:03 am
The Zyprexa documents were leaked from an ongoing product liability lawsuit against Eli Lilly. [read post]
20 Aug 2010, 12:56 pm
Significant Case Studies Give You The Chance To Learn About New Partnerships and New Agreements In The Industry * BMS and Allergan * Merck and Schering-Plough * Sanofi-Aventis and Intelliject * J&J and Takeda * Eli Lilly and Kowa Pharmaceuticals * Eli Lilly and Incyte Corporation The Perfect Pitch: Biotech Investment Challenge In this groundbreaking session, Biotech companies will have the chance to present your new research and new therapies (either in early… [read post]
2 Feb 2011, 3:52 am
General Technical symposium to address access to medicines, patent information and freedom to operate (WIPO) Brazil: Brazilian Attorney General of the Union restricts ANVISA’s role in pharmaceutical patent review (PatentlyBIOtech) India: Protection of Plant Varieties and Farmers’ Rights Authority appoints new Chairperson (Spicy IP) Italy: Tribunale di Milano: Mere filing of application for marketing authorization of a generic drug does not constitute infringing activity: Eli… [read post]
24 Jun 2014, 6:38 am
Apparently, the MDL plaintiffs weren’t satisfied with their win on spoliation or with their equally ridiculous trial verdict, so this time they went after Eli Lilly asking the court to use its inherent power to strike Lilly’s answer to the complaint and to enter default judgment in favor of plaintiffs. [read post]
15 May 2017, 12:00 am
Eli Lilly and Company – United States District Court – Eastern District of Texas – March 17th, 2017) is one of patent infringement. [read post]
15 May 2017, 12:00 am
Eli Lilly and Company – United States District Court – Eastern District of Texas – March 17th, 2017) is one of patent infringement. [read post]
26 Feb 2016, 7:20 am
These SGLT2 drugs are currently approved for use by patients in the US: Invokana (canagliflozin) — Janssen Pharmaceuticals — FDA Approval: 2013 Invokamet (canagliflozin and metformin) — Janssen Pharmaceuticals — FDA Approval: 2014 Farxiga (dapagliflozin) — AstraZeneca Pharmaceuticals — FDA Approval: 2014 Xigduo XR (dapagliflozin and metformin extended-release) — AstraZeneca Pharmaceuticals — FDA Approval: 2014 Jardiance (empagliflozin) —… [read post]
24 Aug 2017, 6:45 am
In June 2006 Health Canada issued a Public Communication alerting Canadians that the drug companies Eli Lilly (Cialis), Bayer (Levitra), and Pfizer (Viagra) were in the process of sending a so-called "Dear Doctor" letter to inform healthcare providers in Canada about changes to the respective package insert, or label, for these drugs regarding this vision loss, or NAION, side effect. [read post]
6 Jan 2010, 3:32 am
(Patent Docs) Products Angiomax (Bivalirudin) – US: Medicines Company files patent infringement complaints against Pliva Hrvatska and Teva following Para IV challenge (Patent Docs) (Patent Docs) (IP Factor) Emend (Fosaprepitant dimeglumine) – US: FDA issues exclusivity decision for Merck’s Emend; Agency reverses course and grants NCE exclusivity (FDA Law Blog) Gemzar (Gemcitabine) – US: Eli Lilly in new patent fight for chemotherapy drug (GenericsWeb)… [read post]
16 Apr 2019, 3:14 am
With a background in and love for intellectual property law, it was not long before Paul was leading Baker McKenzie's global IP practice acting for clients including Cisco, L'Oréal, HP, JCB, British American Tobacco and Eli Lilly. [read post]
15 Jul 2020, 3:23 am
Haier judgment (discussed on the IPKat here) given the SEP/FRAND context.JUVE Patent reported on the German Federal Supreme Court's decision to uphold Eli Lilly's pemetrexed patent (a judgment in parallel Dutch proceedings is anticipated), as well as the Düsseldorf Regional Court's decision to uphold Hanwha Q-Cells' solar technology patent infringement complaint.Trade MarksMany different US organisations use the phrase 'Black Lives… [read post]
4 Nov 2014, 11:58 am
”So, it can be very frustrating to the public and particularly to interveners when a case is discontinued and certain questions that are obviously of “public importance” may be left in limbo, even though the decision below technically is left standing.In today’s discontinued case, the “promise doctrine” and “utility” are also very much are the heart of the Eli Lilly NAFTA Chapter 11 investor/state challenge, although today’s… [read post]
16 Jan 2013, 8:46 am
Eli Lilly and Co., 598 F.3d 1336, 1351 (Fed. [read post]
7 Dec 2023, 6:00 am
The JPML issued a Transfer Order to centralize lawsuits alleging that drug manufacturers and pharmacy benefit manufacturers (PBMs) engaged in an unfair and deceptive conspiracy to orchestrate an insulin pricing scheme.Defendants in these actions include insulin manufacturers Eli Lilly and Company, Novo Nordisk, Inc., and Sanofi-Aventis U.S. [read post]
3 Oct 2013, 11:05 am
The IBLN Steering Committee, with representation from the City of Indianapolis, Indianapolis Yellow Cab, Eli Lilly, WellPoint, Teachers Credit Union and the YMCA of Greater Indianapolis, hosts networking and educational opportunities for central Indiana employers to share best practices and information regarding the inclusion of individuals with disabilities in the diversity planning process. [read post]
27 Dec 2012, 7:50 am
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
16 Sep 2013, 6:27 am
| Al Jazeera America Judge in Spain Partitions Home of Feuding Couple Appeals court upholds slugger Barry Bonds' conviction Pamela Wallin repays $100K in expenses, blames Senate 'lynch mob' Eli Lilly files $500M NAFTA suit against Canada over drug patents - Business - CBC News Federal judge rules government does not have to release Guantanamo videotapes Quebec charter echoes darker times Zimmerman prosecutor takes hit in court of public opinion Ikea Monkey Won't Be Returned To… [read post]
7 Dec 2018, 2:23 pm
”AbbVie, 764 F.3d at 1372 (citing Eli Lilly & Co. v. [read post]
27 Jun 2017, 5:45 pm
Eli Lilly & Co., 598 F.3d 1336, 1351(Fed. [read post]
7 Aug 2023, 6:01 am
Martinotti, who presides over the three most advanced actions related to the alleged insulin pricing scheme.The newly formed Insulin Price-Fixing MDL (No. 3080) will serve to "avoid duplication of discovery, prevent inconsistent pretrial rulings, and to conserve the resources of the parties, their counsel and the judiciary," the panel explains on its website.Defendants in these actions include insulin manufacturers Eli Lilly and Company, Novo Nordisk, Inc., and… [read post]
